| Dr Zeina Nadim Haidar, MD | |
|
100 Florida St, Charleston, WV 25302-1131 | |
| (304) 414-4015 | |
| Not Available |
| Full Name | Dr Zeina Nadim Haidar |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 100 Florida St, Charleston, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275704363 | NPI | - | NPPES |
| 6700356000 | Medicaid | WV | |
| 1275704363 | Other | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 19459 (West Virginia) | Primary |
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194759290 PECOS PAC ID: 4587568134 Enrollment ID: O20031125000177 |
News Archive
More and more studies confirm that sitting is bad for our health, increasing the likelihood of developing cardiovascular disease and other lifestyle-related illnesses such as diabetes.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
The latest GOP proposal being floated in the House exposes Medicaid to heavy cuts because of the plan's cap on federal spending. Meanwhile, some advocates question the commitment of some Democrats to defending the program.
Ipsen today announced that its partner, Inspiration Biopharmaceuticals, Inc., has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) for the treatment and prevention of bleeding in individuals with hemophilia B.
› Verified 1 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Public Health/welfare Agency |
| Entity Identifiers | NPI Number: 1740450089 PECOS PAC ID: 4587568134 Enrollment ID: O20080807000128 |
News Archive
More and more studies confirm that sitting is bad for our health, increasing the likelihood of developing cardiovascular disease and other lifestyle-related illnesses such as diabetes.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
The latest GOP proposal being floated in the House exposes Medicaid to heavy cuts because of the plan's cap on federal spending. Meanwhile, some advocates question the commitment of some Democrats to defending the program.
Ipsen today announced that its partner, Inspiration Biopharmaceuticals, Inc., has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) for the treatment and prevention of bleeding in individuals with hemophilia B.
› Verified 1 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578073706 PECOS PAC ID: 4587568134 Enrollment ID: O20180312001821 |
News Archive
More and more studies confirm that sitting is bad for our health, increasing the likelihood of developing cardiovascular disease and other lifestyle-related illnesses such as diabetes.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
The latest GOP proposal being floated in the House exposes Medicaid to heavy cuts because of the plan's cap on federal spending. Meanwhile, some advocates question the commitment of some Democrats to defending the program.
Ipsen today announced that its partner, Inspiration Biopharmaceuticals, Inc., has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) for the treatment and prevention of bleeding in individuals with hemophilia B.
› Verified 1 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790276525 PECOS PAC ID: 4587568134 Enrollment ID: O20181102002547 |
News Archive
More and more studies confirm that sitting is bad for our health, increasing the likelihood of developing cardiovascular disease and other lifestyle-related illnesses such as diabetes.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
The latest GOP proposal being floated in the House exposes Medicaid to heavy cuts because of the plan's cap on federal spending. Meanwhile, some advocates question the commitment of some Democrats to defending the program.
Ipsen today announced that its partner, Inspiration Biopharmaceuticals, Inc., has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) for the treatment and prevention of bleeding in individuals with hemophilia B.
› Verified 1 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396237434 PECOS PAC ID: 4587568134 Enrollment ID: O20190517001924 |
News Archive
More and more studies confirm that sitting is bad for our health, increasing the likelihood of developing cardiovascular disease and other lifestyle-related illnesses such as diabetes.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
The latest GOP proposal being floated in the House exposes Medicaid to heavy cuts because of the plan's cap on federal spending. Meanwhile, some advocates question the commitment of some Democrats to defending the program.
Ipsen today announced that its partner, Inspiration Biopharmaceuticals, Inc., has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) for the treatment and prevention of bleeding in individuals with hemophilia B.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zeina Nadim Haidar, MD 301 Great Teays Blvd Ste 6, Scott Depot, WV 25560-9552 Ph: (304) 757-6999 | Dr Zeina Nadim Haidar, MD 100 Florida St, Charleston, WV 25302-1131 Ph: (304) 414-4015 |
News Archive
More and more studies confirm that sitting is bad for our health, increasing the likelihood of developing cardiovascular disease and other lifestyle-related illnesses such as diabetes.
The patent application for Microdroplet botulinum toxin, a treatment that improves facial features without detracting from facial expressiveness, has been allowed to inventor Dr. Kenneth D. Steinsapir, M.D. on September 2, 2010.
The latest GOP proposal being floated in the House exposes Medicaid to heavy cuts because of the plan's cap on federal spending. Meanwhile, some advocates question the commitment of some Democrats to defending the program.
Ipsen today announced that its partner, Inspiration Biopharmaceuticals, Inc., has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) for the treatment and prevention of bleeding in individuals with hemophilia B.
› Verified 1 days ago
Dr. John M Eckerd, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 830 Pennsylvania Ave, Suite 103, Charleston, WV 25302 Phone: 304-388-1552 Fax: 304-388-1577 | |
Jennifer Anne Hines, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Florida St, Charleston, WV 25302 Phone: 304-414-4015 Fax: 304-414-4018 | |
Jane Elizabeth Nicholas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 800 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-414-1880 Fax: 304-414-1886 | |
Afif S Habash, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4920 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-442-8117 | |
Mrs. Mary C Pozega, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5324 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-925-7001 Fax: 304-925-7234 | |
Youmna Mousattat, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 800 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-388-2525 | |
Dr. Stefan Randolph Maxwell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 830 Pennsylvania Ave, Suite 406, Charleston, WV 25302 Phone: 304-388-2238 Fax: 304-388-2243 |